PDS Biotechnology
Price & Volume
Stats
See moreOpen | $2.14 |
Previous Close | $2.20 |
Day Range | $2.11-$2.18 |
52W Range | $1.53-$6.68 |
Market Cap | $82.3M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.17 |
News
See moreYahoo Finance • 12 months ago
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
Yahoo Finance • last year
PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update
Yahoo Finance • last year
PDS Biotech Announces Updated Survival Data from NCI-Led Phase 2 Clinical Trial of PDS0101-Based Triple Combination Therapy in Advanced HPV16-Positive Cancer Patients which Show 75% Survival of ICI Naïve Patients at 36 Months
Yahoo Finance • last year
PDS Biotechnology Announces Conference Call and Webcast for Third Quarter 2023 Financial Results
About
CEO | Dr. Frank K. Bedu-Addo Ph.D. |
CFO | Mr. Lars Robert Boesgaard M.B.A. |
Address | 303A College Road East, Princeton, NJ, United States, 08540 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
